未折叠蛋白反应通路作为胰腺癌放射增敏靶点的鉴定
本研究在38株小鼠胰腺导管腺癌细胞系中筛选放射抵抗相关通路,发现未折叠蛋白反应(UPR)在放射抵抗细胞系中高表达;联合IRE1α抑制剂KIRA8或ATF6抑制剂Ceapin-A7与放疗可在放射抵抗细胞系中观察到放射增敏效应,而在放射敏感细胞系中未见明显改变。
要点
- UPR通路在放射抵抗的PDAC细胞系中高表达。
- KIRA8或Ceapin-A7联合放疗在放射抵抗细胞系中显示放射增敏效应。
- 放射增敏机制涉及凋亡增加和G1期细胞周期阻滞。
核心结论
- 数据表明UPR参与PDAC的放射抵抗,UPR抑制的放射增敏效应似乎由凋亡增加和G1期细胞周期阻滞所致,这些发现支持开发新的联合治疗策略以克服放射抵抗。
研究设计与样本
- 使用Alamar Blue增殖实验和集落形成实验(CFA)测定38株小鼠PDAC细胞系的放射反应,并进行基因集富集分析以揭示差异表达通路。
- 使用CFA、细胞周期分布、γH2AX FACS分析和Caspase 3/7 SYTOX实验检测IRE1α抑制剂KIRA8和ATF6抑制剂Ceapin-A7联合治疗的效果。
主要发现
- 未折叠蛋白反应(UPR)被鉴定为在放射抵抗细胞系中高表达的通路。
- 在放射抵抗细胞系中,IRE1α抑制剂KIRA8或ATF6抑制剂Ceapin-A7联合放疗观察到放射增敏效应,而在放射敏感细胞系中放射反应未见实质性改变。
- 在放射抵抗细胞系中观察到KIRA8联合放疗增加凋亡,ATF6抑制联合放疗导致G1期细胞周期阻滞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Due to the high intrinsic radioresistance of pancreatic ductal adenocarcinoma (PDAC), radiotherapy (RT) is only beneficial in 30% of patients. Therefore, this study aimed to identify targets to improve the efficacy of RT in PDAC. MATERIALS AND METHODS: Alamar Blue proliferation and colony formation assay (CFA) were used to determine the radioresponse of a cohort of 38 murine PDAC cell lines. A gene set enrichment analysis was performed to reveal differentially expressed pathways. CFA, cell cycle distribution, γH2AX FACS analysis, and Caspase 3/7 SYTOX assay were used to examine the effect of a combination treatment using KIRA8 as an IRE1α-inhibitor and Ceapin-A7 as an inhibitor against ATF6. RESULTS: The unfolded protein response (UPR) was identified as a pathway highly expressed in radioresistant cell lines. Using the IRE1α-inhibitor KIRA8 or the ATF6-inhibitor Ceapin-A7 in combination with radiation, a radiosensitizing effect was observed in radioresistant cell lines, but no substantial alteration of the radioresponse in radiosensitive cell lines. Mechanistically, increased apoptosis by KIRA8 in combination with radiation and a cell cycle arrest in the G1 phase after ATF6 inhibition and radiation have been observed in radioresistant cell lines. CONCLUSION: So, our data show evidence that the UPR is involved in radioresistance of PDAC. Increased apoptosis and a G1 cell cycle arrest seem to be responsible for the radiosensitizing effect of UPR inhibition. These findings are supportive for developing novel combination treatment concepts in PDAC to overcome radioresistance.
引用
- Kern J, Schilling D, Schneeweis C, et al. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. Radiother Oncol. 2023. PMID: 38135186. doi:10.1016/j.radonc.2023.110059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。